Genopathy
Gene-Disorder Association · Article
Gene
LOC107963955
BCR-ABL Major-Breakpoint Cluster Region
Disorder
Chronic Myelogenous Leukemia, Bcr-Abl1 Positive
First reported 1950
Key publication · disorder Ethyl carbamate (urethane) in the treatment of chronic myelocytic leukemia; results of a three-year study.The Medical clinics of North America · 1950
Manually curated
Association Review

In brief

The association between LOC107963955 (BCR-ABL Major-Breakpoint Cluster Region) and Chronic Myelogenous Leukemia, Bcr-Abl1 Positive is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
LOC107963955

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Chronic Myelogenous Leukemia, Bcr-Abl1 Positive

The disorder

5 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Provenance

References & sources

2 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access